ACTIVE

Herseltpharma

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

268,8 k €

+180.3% YoY

Gross margin

821,5 k €

+45.9% YoY

Equity

920 k €

+16.8% YoY

Workforce

3,7 ETP

0.0% YoY

What does Herseltpharma do?

Herseltpharma is a Private limited company incorporated in 2007. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Herselt. It employs on average 3,7 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0892.542.332

Incorporation

04/10/2007

Legal form

Private limited company

Registered office

Dorp 50
2230 Herselt · FlandreSee on map

Contributed capital

63 600,00 €

Latest accounts

31/12/2025

Average workforce

3,7 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 64200Activities of holding companies 64210Activities of holding companies

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008
Income statement
Gross margin	821,5 k €	+45.9%	563,1 k €	+11.1%	506,8 k €	+12.9%	449,1 k €	+16.3%	386,1 k €	-4.3%	403,3 k €	-1.7%	410,1 k €	-1.8%	417,6 k €	+439%	77,5 k €	-21.1%	98,2 k €	-8.1%	106,8 k €	+2.6%	104,1 k €	-2.9%	107,3 k €	+6.9%	100,4 k €	-13.4%	115,9 k €	+28.9%	89,9 k €	+5.6%	85,1 k €	-1.3%	86,3 k €
EBITDA	577,2 k €	+62.3%	355,7 k €	+9.0%	326,4 k €	+20.3%	271,3 k €	+27.7%	212,5 k €	-16.4%	254,2 k €	-2.0%	259,3 k €	+6.4%	243,7 k €	+215%	77,3 k €	-21.0%	97,8 k €	-6.7%	104,8 k €	+3.0%	101,8 k €	-3.3%	105,2 k €	+6.9%	98,4 k €	-11.1%	110,8 k €	+31.6%	84,2 k €	+30.4%	64,6 k €	-24.5%	85,5 k €
Operating result	443,3 k €	+111%	210,5 k €	-11.2%	237,1 k €	+41.0%	168,1 k €	+54.1%	109,1 k €	-27.4%	150,2 k €	-2.5%	154 k €	+8.7%	141,7 k €	+132%	61,2 k €	-22.4%	78,9 k €	-6.2%	84,1 k €	+5.3%	79,8 k €	-3.5%	82,6 k €	+0.8%	82 k €	-13.0%	94,2 k €	+39.0%	67,7 k €	+23.9%	54,7 k €	+16.5%	46,9 k €
Net result	268,8 k €	+180%	95,9 k €	-26.3%	130,2 k €	+53.2%	85 k €	+108%	40,8 k €	-41.7%	69,9 k €	+4.7%	66,8 k €	+20.0%	55,7 k €	+131%	24,1 k €	-51.8%	50,1 k €	+6.6%	46,9 k €	+43.3%	32,8 k €	-4.0%	34,1 k €	+6.1%	32,2 k €	-10.1%	35,8 k €	+87.9%	19 k €	+107%	9,2 k €	+462%	1,6 k €
Balance sheet
Equity	920 k €	+16.8%	788 k €	+13.9%	692,1 k €	+12.1%	617,6 k €	+16.0%	532,6 k €	+8.3%	491,8 k €	+16.6%	421,9 k €	+18.8%	355,1 k €	+18.6%	299,4 k €	+8.8%	275,3 k €	+22.2%	225,2 k €	+26.3%	178,3 k €	+77.4%	100,5 k €	-13.6%	116,4 k €	+38.2%	84,2 k €	+73.8%	48,5 k €	+64.7%	29,4 k €	+45.4%	20,2 k €
Total assets	1,3 M €	-14.1%	1,5 M €	-2.8%	1,6 M €	+4.4%	1,5 M €	-0.4%	1,5 M €	-6.4%	1,6 M €	-4.6%	1,7 M €	-4.7%	1,8 M €	+112%	835,7 k €	-3.7%	867,7 k €	-5.4%	917,5 k €	-0.7%	923,8 k €	-1.9%	942 k €	+4.3%	902,9 k €	-1.3%	914,4 k €	+0.9%	906,1 k €	+3.1%	879 k €	-0.2%	881,1 k €
Cash	110,9 k €	+2.9%	107,8 k €	-47.5%	205,5 k €	+121%	93 k €	+22.3%	76 k €	-19.8%	94,8 k €	+25.4%	75,6 k €	+36.2%	55,5 k €	+8513%	644,5 €	-96.1%	16,6 k €	+45.7%	11,4 k €	+54.4%	7,4 k €	-55.5%	16,5 k €	+519%	2,7 k €	+46805%	5,7 €	-99.9%	7,4 k €	+313%	1,8 k €	-94.9%	35,5 k €
Debts	391,9 k €	-45.9%	724,4 k €	-16.8%	870,2 k €	-1.1%	879,9 k €	-9.3%	969,7 k €	-13.0%	1,1 M €	-11.7%	1,3 M €	-10.6%	1,4 M €	+163%	536,3 k €	-9.5%	592,4 k €	-10.6%	662,9 k €	-7.6%	717,5 k €	-11.8%	813,4 k €	+7.3%	758,4 k €	-5.4%	802,1 k €	-3.7%	832,6 k €	+0.4%	829 k €	-3.6%	859,9 k €
Other
Workforce	3,7 ETP	0.0%	3,7 ETP	+5.7%	3,5 ETP	-2.8%	3,6 ETP	0.0%	3,6 ETP	+12.5%	3,2 ETP		–		–		–		–		–		–		–		–		–		0,1 ETP		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Kathleen Gielis

Director

Active

Ended mandates

Dominique Torfs

Manager · since 01 janvier 2008

Ended

Patrick Van Mechelen

Manager · since 04 octobre 2007

Ended

Kathleen Gielis

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	16/06/2026	04/08/2025	12/07/2024	17/07/2023	14/07/2022	20/07/2021
General meeting	15/06/2026	16/06/2025	17/06/2024	19/06/2023	20/06/2022	21/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	15/06/2026	16/06/2026	Dutch	PDF
Abridged model	31/12/2024	16/06/2025	04/08/2025	Dutch	PDF
Abridged model	31/12/2023	17/06/2024	12/07/2024	Dutch	PDF
Abridged model	31/12/2022	19/06/2023	17/07/2023	Dutch	PDF
Abridged model	31/12/2021	20/06/2022	14/07/2022	Dutch	PDF
Abridged model	31/12/2020	21/06/2021	20/07/2021	Dutch	PDF
Micro model	31/12/2019	15/06/2020	13/07/2020	Dutch	PDF
Micro model	31/12/2018	17/06/2019	02/07/2019	Dutch	PDF
Micro model	31/12/2017	18/06/2018	09/07/2018	Dutch	PDF
Micro model	31/12/2016	19/06/2017	06/07/2017	Dutch	PDF
Abridged model	31/12/2015	20/06/2016	09/08/2016	Dutch	PDF
Abridged model	31/12/2014	15/06/2015	17/08/2015	Dutch	PDF
Abridged model	31/12/2013	16/06/2014	25/08/2014	Dutch	PDF
Abridged model	31/12/2012	17/06/2013	30/08/2013	Dutch	PDF
Abridged model	31/12/2011	18/06/2012	27/06/2012	Dutch	PDF
Abridged model	31/12/2010	20/06/2011	11/07/2011	Dutch	PDF
Abridged model	31/12/2009	21/06/2010	28/06/2010	Dutch	PDF
Abridged model	31/12/2008	15/06/2009	12/07/2009	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Kathleen Gielis

Director

Active

Ended mandates

Dominique Torfs

Manager · since 01 janvier 2008

Ended

Patrick Van Mechelen

Manager · since 04 octobre 2007

Ended

Kathleen Gielis

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring24/05/2024
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring01/03/2024
KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates15/01/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Registered office02/02/2018
BENAMING - MAATSCHAPPELIJKE ZETEL - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates16/09/2016
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares25/03/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates11/05/2012
ONTSLAGEN - BENOEMINGEN
PDF
Other12/10/2007
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025268,8 k €↑
2024
Annual accounts 202495,9 k €↓
2023
Annual accounts 2023130,2 k €↑
2022
Annual accounts 202285 k €↑
2021
Annual accounts 202140,8 k €↓
2020
Annual accounts 202069,9 k €↑
2019
Annual accounts 201966,8 k €↑
2018
Annual accounts 201855,7 k €↑
2017
Annual accounts 201724,1 k €↓
2016
Annual accounts 201650,1 k €↑
2015
Annual accounts 201546,9 k €↑
2014
Annual accounts 201432,8 k €↓
2013
Annual accounts 201334,1 k €↑
2012
Annual accounts 201232,2 k €↓
2011
Annual accounts 201135,8 k €↑
2010
Annual accounts 201019 k €↑
2009
Annual accounts 20099,2 k €↑
2008
Annual accounts 20081,6 k €
04/10/2007
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Herseltpharma

Overview

What does Herseltpharma do?

Trend over 18 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline